Related Experiment Videos
Serodiagnosis of American trypanosomosis by using nonpathogenic trypanosomatid antigen
V M Monteón1, L Guzmán-Rojas, C Negrete-García
1División Auxiliar de Diagnóstico y Tratamiento, Instituto Nacional de Cardiología Ignacio Chávez, Mexico D.F. , Mexico.
Insights
Crithidia luciliae offers a promising alternative antigen for Chagas' disease serodiagnosis. This nonpathogenic trypanosomatid demonstrated high sensitivity and specificity in ELISA and Western blot assays, identifying a key 30 kDa protein band.
Area of Science:
- Parasitology
- Immunology
- Tropical Medicine
Background:
- Chagas' disease diagnosis relies on detecting antibodies against Trypanosoma cruzi.
- Current diagnostic methods may face limitations in sensitivity or specificity.
- Alternative antigen sources are needed for improved serodiagnosis.
Purpose of the Study:
- To evaluate Crithidia luciliae as a potential antigen source for Chagas' disease serodiagnosis.
- To compare the diagnostic performance of C. luciliae crude extracts with Trypanosoma cruzi crude extracts.
- To identify specific antigenic components within C. luciliae.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) using crude extracts of C. luciliae and T. cruzi.
- Western blotting to identify specific immunogenic protein bands.
- Testing human serum samples from Chagas' disease patients and individuals with other conditions.
Main Results:
- ELISA showed 100% sensitivity and 83% specificity with C. luciliae crude extract.
- Western blotting identified a 30 kDa immunodominant band in C. luciliae recognized by chagasic sera, achieving 97% specificity.
- Carbohydrate moieties in C. luciliae were found to be non-antigenic.
Conclusions:
- Crithidia luciliae is a viable and effective antigen source for Chagas' disease serodiagnosis.
- The 30 kDa protein from C. luciliae shows high specificity for detecting Chagas' disease antibodies.
- This approach offers a potential improvement over existing diagnostic strategies for Chagas' disease.
Abstract:
Crithidia luciliae, a nonpathogenic trypanosomatid, could provide a good alternative source of antigen for serodiagnosis of Chagas' disease. An enzyme-linked immunosorbent assay showed 100% sensitivity and 83% specificity when 91 human serum samples from Chagas' disease patients and 127 human serum samples from people suffering from toxoplasmosis (21 samples), leishmaniasis (32 samples), systemic rheumatic diseases (33 samples), and heart diseases (41 samples) were tested simultaneously with Trypanosoma cruzi and C. luciliae crude extracts. By Western blotting, an immunodominant band (30 kDa) was recognized by chagasic sera on the C. luciliae crude extract; specificity reached 97% with respect to this protein band. The carbohydrate moieties were not antigenic.